Table 1Pharmacokinetic Classification of Benzodiazepines Available in Canada2

From: 1, CONTEXT AND POLICY ISSUES

Cover of Benzodiazepines in Older Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
Benzodiazepines in Older Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet].
McIntosh B, Clark M, Spry C.
Copyright © CADTH (January 2011)

You are permitted to make copies of this document for non-commercial purposes provided it is not modified when reproduced and appropriate credit is given to CADTH.

Links: This document may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third-party sites is governed by the owners’ own terms and conditions set out for such sites. CADTH does not make any guarantee with respect to any information contained on such third-party sites and CADTH is not responsible for any injury, loss, or damage suffered as a result of using such third-party sites.

Industry: The following manufacturers were provided with an opportunity to comment on an earlier version of this report: Sepracor Pharmaceuticals Inc., Hoffmann-La Roche Ltd., and Pfizer Canada Inc. All comments that were received were considered when preparing the final report.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.